Ray Kurzweil Reader Pdf 6-20-03
Acknowledgements The essays in this collection were published on KurzweilAI.net during 2001-2003, and have benefited from the devoted efforts of the KurzweilAI.net editorial team. Our team includes Amara D. Angelica, editor; Nanda Barker-Hook, editorial projects manager; Sarah Black, associate editor; Emily Brown, editorial assistant; and Celia Black-Brooks, graphics design manager and vice president of business development. Also providing technical and administrative support to KurzweilAI.net are Ken Linde, systems manager; Matt Bridges, lead software developer; Aaron Kleiner, chief operating and financial officer; Zoux, sound engineer and music consultant; Toshi Hoo, video engineering and videography consultant; Denise Scutellaro, accounting manager; Joan Walsh, accounting supervisor; Maria Ellis, accounting assistant; and Don Gonson, strategic advisor. —Ray Kurzweil, Editor-in-Chief TABLE OF CONTENTS LIVING FOREVER 1 Is immortality coming in your lifetime? Medical Advances, genetic engineering, cell and tissue engineering, rational drug design and other advances offer tantalizing promises. This section will look at the possibilities. Human Body Version 2.0 3 In the coming decades, a radical upgrading of our body's physical and mental systems, already underway, will use nanobots to augment and ultimately replace our organs. We already know how to prevent most degenerative disease through nutrition and supplementation; this will be a bridge to the emerging biotechnology revolution, which in turn will be a bridge to the nanotechnology revolution. By 2030, reverse-engineering of the human brain will have been completed and nonbiological intelligence will merge with our biological brains. Human Cloning is the Least Interesting Application of Cloning Technology 14 Cloning is an extremely important technology—not for cloning humans but for life extension: therapeutic cloning of one's own organs, creating new tissues to replace defective tissues or organs, or replacing one's organs and tissues with their "young" telomere-extended replacements without surgery.
[Show full text]